• ‘Rare Barometer’ Program Helps Eurordis Shape EU Rare Disease Policy
  • Temozolomide Effective Against Cushing’s Caused by Aggressive Tumors, Case Report Suggests
  • Endoscopic Endonasal Surgery is Safe, Effective for Treating Cushing’s Patients, Study Concludes
  • Hormonal Stimulation Improves Tumor Detection in Cushing’s, Study Finds
  • HRA Pharma Prepares Observational Post-Approval Study of Ketoconazole
  • Cushing’s Patients with Excess Prolactin Respond Well to Dopamine Agonists, Report Suggests
  • Surgical Removal of Pituitary Adenomas Through the Nose Remains an Effective Treatment for Pediatric Patients, Study Finds
  • Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries
  • EU Committee Recommends Giving Relacorilant Orphan Drug Status for Cushing’s Syndrome
  • Mifepristone May Benefit Patients with Mild Autonomous Cortisol Secretion, Pilot Trial Shows
  • Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns
  • Signifor Normalizes Cortisol Levels in Cushing’s Disease Patients, Real-world Study Shows